Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

According to the arrest documents, two of the drugs found in the lollipops are the active ingredients of popular weight-loss ...

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to investigate whether shortages of the drug, which is sold by Lilly as ...

The strong growth for Lilly's tirzepatide products came after market leader Novo Nordisk reported the first signs of weaker growth for its rival semaglutide products – Ozempic for diabetes and W ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Tirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study publi ...

By removing both semaglutide and tirzepatide (the actives in Wegovy ... same manufacturing guidelines as drugmakers to ensure their products are safe, sterile (if applicable), and stable, usually ...

In a new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT), investigators evaluated biomarkers for ...

Semaglutide and tirzepatide were the least cost-effective of four obesity drugs examined in a microsimulation model. A multifaceted approach is needed to reduce financial barriers to obesity ...

Orally Delivered Tirzepatide Unexpectedly Reaches End of ... potential adverse effects arising from the testing or use of products utilizing the DehydraTECH technology, the Company's ability ...